BISECCO, Alvino
 Distribuzione geografica
Continente #
EU - Europa 6.505
AS - Asia 2.344
NA - Nord America 1.691
SA - Sud America 475
AF - Africa 36
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.061
Nazione #
RU - Federazione Russa 4.193
US - Stati Uniti d'America 1.644
IT - Italia 990
SG - Singapore 809
CN - Cina 554
IE - Irlanda 478
BR - Brasile 389
HK - Hong Kong 372
DE - Germania 167
VN - Vietnam 156
GB - Regno Unito 145
KR - Corea 136
AT - Austria 130
JP - Giappone 104
IN - India 87
UA - Ucraina 78
FR - Francia 76
SE - Svezia 59
TR - Turchia 44
FI - Finlandia 42
AR - Argentina 41
NL - Olanda 36
GR - Grecia 30
BE - Belgio 21
CA - Canada 19
MX - Messico 18
EC - Ecuador 13
IQ - Iraq 11
BD - Bangladesh 10
CO - Colombia 10
ID - Indonesia 10
MA - Marocco 9
PL - Polonia 9
ES - Italia 8
IR - Iran 8
PY - Paraguay 8
AU - Australia 7
PK - Pakistan 7
ZA - Sudafrica 7
CZ - Repubblica Ceca 6
EG - Egitto 6
LT - Lituania 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IS - Islanda 4
KE - Kenya 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
PT - Portogallo 3
RS - Serbia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TN - Tunisia 2
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
KW - Kuwait 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 11.061
Città #
Moscow 1.477
Dublin 476
Hong Kong 372
Singapore 367
Santa Clara 306
Chandler 173
Seoul 135
Naples 131
Jacksonville 127
Vienna 117
Hefei 114
Beijing 90
Ann Arbor 80
Ashburn 66
Bengaluru 65
Caserta 65
New York 61
Ho Chi Minh City 58
Princeton 56
Roxbury 52
The Dalles 52
Rome 48
Medford 42
Milan 42
Bremen 40
Munich 40
Dallas 38
São Paulo 38
Napoli 33
Hanoi 28
Los Angeles 28
Aversa 25
Nanjing 23
Norwalk 23
Nuremberg 23
Brussels 21
Wilmington 21
London 19
Woodbridge 18
Cambridge 14
Boardman 13
Stockholm 13
Amsterdam 12
Des Moines 12
Verona 12
Falkenstein 11
Genoa 11
Turku 11
Rio de Janeiro 10
Tokyo 10
Turin 10
Jinan 9
Reggio Emilia 9
Brasília 8
Brooklyn 8
Florence 8
Lappeenranta 8
Montreal 8
Quarto 8
San Francisco 8
San Polo 8
Bologna 7
Casoria 7
Ercolano 7
Guangzhou 7
Helsinki 7
Hải Dương 7
Istanbul 7
Phoenix 7
Sala Consilina 7
Baghdad 6
Belo Horizonte 6
Haiphong 6
Padova 6
Rimini 6
San Mateo 6
Brescia 5
Campinas 5
Chennai 5
Chicago 5
Fisciano 5
Lanzhou 5
Mexico City 5
Pisa 5
Porto Alegre 5
Redwood City 5
Shanghai 5
Shenyang 5
Thái Bình 5
Volla 5
Afragola 4
Auburn Hills 4
Belém 4
Biên Hòa 4
Boston 4
Buenos Aires 4
Cairo 4
Cava De' Tirreni 4
Caxias do Sul 4
Dearborn 4
Totale 5.420
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 644
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 186
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 185
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 184
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 184
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 175
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 171
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 161
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 158
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 158
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 157
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 152
Apathy Is Correlated with Widespread Diffusion Tensor Imaging (DTI) Impairment in Amyotrophic Lateral Sclerosis 152
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 150
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 150
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 149
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 146
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 142
Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS) 139
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 137
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 135
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 132
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 132
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 130
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 130
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 130
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 129
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 128
Translational research on cognitive impairment in chronic kidney disease 125
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 125
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 125
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 125
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 124
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 120
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 117
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 116
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 116
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 114
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 114
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 114
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 113
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 112
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 111
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 111
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 111
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 108
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 108
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 108
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 106
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 106
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 105
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 105
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 105
Signs and symptoms of COVID-19 in patients with multiple sclerosis 104
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 104
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 104
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 103
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 102
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 102
Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): A longitudinal MRI one-year study 101
Readability Analysis of Online Headache and Migraine Information 101
Chemotherapy-related cognitive impairment and kidney dysfunction 100
Functional plasticity of the visual system in multiple sclerosis. 99
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 98
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 98
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 98
Microstructural correlates of Edinburgh Cognitive and Behavioural ALS Screen (ECAS) changes in amyotrophic lateral sclerosis 97
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 96
MOG-IgG testing strategies in accordance with the 2023 MOGAD criteria: a clinical-laboratory assessment 95
The relationship between biological sex, cognitive reserve, and cognition in multiple sclerosis 94
Impact of post-contrast MRI in the definition of active multiple sclerosis 93
Two Unexpected Cases of Rosacea during Fingolimod Therapy 93
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey 92
Longitudinal assessment of cognitive function in patients with non-relapsing MOG-IgG associated disease 89
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 89
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 87
Resting state functional MRI brain signatures of fast disease progression in amyotrophic lateral sclerosis: a retrospective study 87
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 84
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: The importance of intrathecal MOG-IgG synthesis 84
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating Disorders 83
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability 83
Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study 77
Listening to the neurological teams for multiple sclerosis: the SMART project 74
MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis 73
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 73
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 72
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 71
Lifespan normative data on rates of brain volume changes 70
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 68
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 64
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 64
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 62
Psychological resilience explains functional variability across people with multiple sclerosis – Commentary 58
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap 53
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 51
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 49
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease 47
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis 46
Splicing-based biomarkers define a robust multigene classifier for relapsing-remitting multiple sclerosis 29
Totale 11.331
Categoria #
all - tutte 34.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 10 55 35 10 26 56 13
2021/2022522 16 20 15 23 123 22 34 23 32 61 37 116
2022/2023867 100 14 23 54 82 57 3 38 439 18 16 23
2023/2024671 36 24 39 75 143 73 63 20 13 16 78 91
2024/20251.904 18 20 27 67 316 234 222 138 286 261 179 136
2025/20266.231 358 492 428 358 673 3.922 0 0 0 0 0 0
Totale 11.331